Safety and Efficacy of the Bi-Aspheric Monofocal IOL
Safety and Efficacy of the Bi-Aspheric Monofocal Intraocular Lens
ICARES Medicus, Inc.
30 participants
Mar 5, 2024
OBSERVATIONAL
Conditions
Summary
This is an observational, single-center, non-control, open-label post-marketing study. Patients implanted with an aspicio™ Monofocal Intraocular Lens will be scheduled for a follow-up visit at least 3 months after the surgery to undergo a routine basic ophthalmological examination.
Eligibility
Inclusion Criteria3
- Subjects 18 years of age or older who have been implanted with aspicio™ monofocal intraocular lens in at least 1 eye
- Willingness to cooperate with and complete all post-operative visits
- Ability to comprehend and sign an informed consent
Exclusion Criteria8
- Any pathology that could reduce Visual Acuity (VA) (including amblyopia, severe corneal dystrophy, diabetic retinopathy, extremely narrow anterior chamber depth, microphthalmos, clinically significant macular/RPE changes, retinal detachment, corneal transplant, chronic sever uveitis, choroidal hemorrhage, recurrent severe inflammation of the anterior or posterior segment of unknown etiology, iris neovascularization, medically controlled or uncontrolled glaucoma, clinically significant macular degeneration, or diagnosis of pseudoexfoliation).
- Previous ocular surgery (including YAG-laser) or trauma
- Clinically significant irregular astigmatism
- Concomitant severe eye disease
- Pregnant or lactating
- Any other ocular or systemic condition which, in the opinion of the investigator, should exclude the subject from the study
- Concurrent participation in another drug or device investigation
- May be expected to require other ocular surgery during the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A bi-aspheric monofocal IOL is implanted through preloaded IOL Delivery System in the capsular bag in the posterior chamber of the eye during cataract surgery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06380478